Relypsa (RLYP) Misses Q4 EPS by 5c; Provides 'Encouraging' Initial Veltassa Script Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Relypsa (RLYP) Misses Q4 EPS by 5c; Provides 'Encouraging' Initial Veltassa Script Data

Relypsa Reports Fourth Quarter and Full Year 2015 Financial Results and Announces Other Corporate Updates

February 24, 2016 4:05 PM EST

Relypsa reports encouraging initial demand for VeltassaVeltassa added to CMS 2016 Formulary Reference File and agreements signed with Express Scripts and CVS Caremark, the two largest pharmacy benefit managers in the United StatesRelypsa plans to submit a supplemental New Drug Application (sNDA) by mid-2016 requesting a label change for Veltassa based on positive results of Phase 1 drug-drug interaction studiesRelypsa and VFMCRP on track to submit European application for Veltassa in first half of 2016Relypsa management to host conference call/webcast this afternoon at 5:00 p.m. ET/2:00... More